Literatur
-
1
Ochoa J.
Recognition of unmyelinated fiber disease: morphologic criteria.
Muscle Nerve.
1978;
1
375-387
-
2
Weidner C, Schmelz M, Schmidt R. et al .
Functional attributes discriminating mechano-insensitive and mechano-responsive C nociceptors in human skin.
J Neurosci.
1999;
19
10184-10190
-
3
Schmelz M, Schmidt R, Bickel A. et al .
Specific C-receptors for itch in human skin.
J Neurosci.
1997;
17
8003-8008
-
4
Ali Z, Carroll M, Robertson K P. et al .
The extent of small fibre sensory neuropathy in diabetics with plantar foot ulceration.
J Neurol Neurosurg Psychiatry.
1989;
52
94-98
-
5
Burchiel K J.
Spontaneous impulse generation in normal and denervated dorsal root ganglia: sensitivity to alpha-adrenergic stimulation and hypoxia.
Exp Neurol.
1984;
85
257-272
-
6
Rolke R, Magerl W, Campbell K A. et al .
Quantitative sensory testing: a comprehensive protocol for clinical trials.
Eur J Pain.
2006;
10
77-88
-
7
Ochoa J L, Yarnitsky D.
The triple cold syndrome. Cold hyperalgesia, cold hypoaesthesia and cold skin in peripheral nerve disease.
Brain.
1994;
117
185-197
-
8
Schattschneider J, Bode A, Wasner G. et al .
Idiopathic restless legs syndrome: abnormalities in central somatosensory processing.
J Neurol.
2004;
251
977-982
-
9
Verdugo R, Ochoa J L.
Quantitative somatosensory thermotest. A key method for functional evaluation of small calibre afferent channels.
Brain.
1992;
115
893-913
-
10
Baron R, Saguer M.
Postherpetic neuralgia. Are C-nociceptors involved in signalling and maintenance of tactile allodynia?.
Brain.
1993;
116
1477-1496
-
11
Bickel A, Kramer H H, Hilz M J. et al .
Assessment of the neurogenic flare reaction in small-fiber neuropathies.
Neurology.
2002;
59
917-919
-
12
Bromm B, Treede R D.
Laser evoked cerebral potentials in the diagnosis of cutaneous pain sensitivity.
Rev Neurol.
1991;
147
625-643
-
13
Herrmann D N, Griffin J W, Hauer P. et al .
Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies.
Neurology.
1999;
53
1634-1640
-
14
Ziegler D, Laux G, Dannehl K. et al .
Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses.
Diabet Med.
1992;
9
166-175
-
15
Baron R, Ewing D J.
Heart rate variability. The International Federation of Clinical Neurophysiology.
Electroencephalogr Clin Neurophysiol Suppl.
1999;
52
283-286
-
16
Hilz M J, Dutsch M.
Methods of quantitative evaluation of the autonomic nerve system.
Nervenarzt.
2005;
76
767-778; quiz 779 - 780
-
17
The Consensus Committee of the American Autonomic Society and the American Academy of Neurology .
Consensus Statement on the definition of orhostatic hypotension, pure autonomic failure and multiple system atrophy.
Neurology.
1996;
46
1470
-
18
Schuller T B, Hermann K, Baron R.
Quantitative assessment and correlation of sympathetic, parasympathetic, and afferent small fiber function in peripheral neuropathy.
J Neurol.
2000;
247
267-272
-
19
Riedl B, Nischik M, Birklein F. et al .
Spatial extension of sudomotor axon reflex sweating in human skin.
J Auton Nerv Syst.
1998;
69
83-88
-
20
Evans B A, Lussky D, Knezevic W.
The peripheral autonomic surface potential in suspected small fiber neuropathy.
Muscle Nerve.
1988;
11
982
-
21
Periquet M I, Novak V, Collins M P. et al .
Painful sensory neuropathy: prospective evaluation using skin biopsy.
Neurology.
1999;
53
1641-1647
-
22
Novak V, Freimer M L, Kissel J T. et al .
Autonomic impairment in painful neuropathy.
Neurology.
2001;
56
861-868
-
23
Singleton J R, Smith A G, Bromberg M B.
Painful sensory polyneuropathy associated with impaired glucose tolerance.
Muscle Nerve.
2001;
24
1225-1228
-
24
McManis P G, Windebank A J, Kiziltan M.
Neuropathy associated with hyperlipidemia.
Neurology.
1994;
44
2185-2186
-
25
Koike H, Mori K, Misu K. et al .
Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status.
Neurology.
2001;
56
1727-1732
-
26
Schattschneider J, Wasner G, Baron R.
Zytostatika induzierte Neuropathien.
Aktuelle Neurologie.
1999;
28
53-61
-
27
Miller R G, Parry G J, Pfaeffl W. et al .
The spectrum of peripheral neuropathy associated with ARC and AIDS.
Muscle Nerve.
1988;
11
857-863
-
28
Lacomis D, Giuliani M J, Steen V. et al .
Small fiber neuropathy and vasculitis.
Arthritis Rheum.
1997;
40
1173-1177
-
29
Holland N R, Crawford T O, Hauer P. et al .
Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases.
Ann Neurol.
1998;
44
47-59
-
30
Mellgren S I, Conn D L, Stevens J C. et al .
Peripheral neuropathy in primary Sjogren's syndrome.
Neurology.
1989;
39
390-394
-
31
Orstavik K, Weidner C, Schmidt R. et al .
Pathological C-fibres in patients with a chronic painful condition.
Brain.
2003;
126
567-578
-
32
Davies B, Bannester R, Sever P. et al .
The pressor actions of noradrenaline, angiotensin II and saralasin in chronic autonomic failure treated with fludrocortisone.
Br J Clin Pharmacol.
1979;
8
253-260
-
33
Jordan J, Shannon J R, Pohar B. et al .
Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure.
J Am Soc Nephrol.
1999;
10
35-42
-
34
Jankovic J, Gilden J L, Hiner B C. et al .
Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine.
Am J Med.
1993;
95
38-48
-
35
Rendell M S, Rajfer J, Wicker P A. et al .
Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.
JAMA.
1999;
281
421-426
-
36
Fonseca V, Seftel A, Denne J. et al .
Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials.
Diabetologia.
2004;
47
1914-1923
-
37
Finnerup N B, Otto M, McQuay H J. et al .
Algorithm for neuropathic pain treatment: an evidence based proposal.
Pain.
2005;
118
289-305
-
38
Rowbotham M C, Goli V, Kunz N R. et al .
Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study.
Pain.
2004;
110
697-706
-
39
Goldstein D J, Lu Y, Detke M J. et al .
Duloxetine vs. placebo in patients with painful diabetic neuropathy.
Pain.
2005;
116
109-118
-
40
Eisenberg E, Lurie Y, Braker C. et al .
Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study.
Neurology.
2001;
57
505-509
-
41
Simpson D M, McArthur J C, Olney R. et al .
Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial.
Neurology.
2003;
60
1508-1514
-
42
Rowbotham M, Harden N, Stacey B. et al .
Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.
JAMA.
1998;
280
1837-1842
-
43
Backonja M, Beydoun A, Edwards K R. et al .
Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.
JAMA.
1998;
280
1831-1836
-
44
Gorson K C, Schott C, Herman R. et al .
Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial.
J Neurol Neurosurg Psychiatry.
1999;
66
251-252
-
45
Rice A S, Maton S.
Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study.
Pain.
2001;
94
215-224
-
46
Dworkin R H, Corbin A E, Young J P.
Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial.
Neurology.
2003;
22
1274-1283
-
47
Sabatowski R, Galvez R, Cherry D A. et al .
Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.
Pain.
2004;
109
26-35
-
48
Frampton J E, Scott L J.
Pregabalin: in the treatment of painful diabetic peripheral neuropathy.
Drugs.
2004;
64
2813-2820
-
49
Lesser H, Sharma U, LaMoreaux L. et al .
Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.
Neurology.
2004;
63
2104-2110
-
50
Frampton J E, Foster R H.
Pregabalin: in the treatment of postherpetic neuralgia.
Drugs.
2005;
65
111-118
-
51
Harke H, Gretenkort P, Ladleif H U. et al .
The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study.
Anesth Analg.
2001;
92
488-495
-
52
Harati Y, Gooch C, Swenson M. et al .
Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy [In Process Citation].
Neurology.
1998;
50
1842-1846
-
53
Sindrup S H, Andersen G, Madsen C. et al .
Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.
Pain.
1999;
83
85-90
-
54
Gobel H, Stadler T.
Treatment of post-herpes zoster pain with tramadol. Results of an open pilot study versus clomipramine with or without levomepromazine.
Drugs.
1997;
53, Suppl 2
34-39
-
55
Gimbel J S, Richards P, Portenoy R K.
Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial.
Neurology.
2003;
60
927-934
-
56
Watson C P, Moulin D, Watt-Watson J. et al .
Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy.
Pain.
2003;
105
71-78
-
57
Baron R, Maier C.
Opioidtherapie neuropathischer Schmerzen.
Akt Neurol.
2000;
27
332-339
-
58
Ziegler D, Hanefeld M, Ruhnau K J. et al .
Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
Diabetologia.
1995;
38
1425-1433
-
59
Ziegler D, Reljanovic M, Mehnert H. et al .
Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
Exp Clin Endocrinol Diabetes.
1999;
107
421-430
-
60
Ziegler D, Hanefeld M, Ruhnau K J. et al .
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
Diabetes Care.
1999;
22
1296-1301
-
61
Ametov A S, Barinov A, Dyck P J. et al .
The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
Diabetes Care.
2003;
26
770-776
-
62
Ziegler D, Nowak H, Kempler P. et al .
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.
Diabet Med.
2004;
21
114-121
J. Schattschneider
Universitätsklinikum Schleswig-Holstein, Campus Kiel, Sektion für neurologische Schmerzforschung und -therapie
Schittenhelmstraße 10
24103 Kiel
Email: j.schattschneider@neurologie.uni-kiel.de
